Cargando…
Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
Cervical cancer (CC) poses a serious threat to women’s health. Although many early-stage patients have a good prognosis, there are still a lack of effective therapies for advanced and recurrent/metastatic CC. In this context, immunotherapy and immune checkpoint inhibitors (ICIs) are particularly lik...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582347/ https://www.ncbi.nlm.nih.gov/pubmed/36276090 http://dx.doi.org/10.3389/fonc.2022.996495 |